tradingkey.logo

Core Laboratories Inc

CLB
15.350USD
+0.060+0.39%
Close 11/07, 16:00ETQuotes delayed by 15 min
707.43MMarket Cap
22.02P/E TTM

Core Laboratories Inc

15.350
+0.060+0.39%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Core Laboratories Inc

Currency: USD Updated: 2025-11-07

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. The company is performing strongly in the stock market, with strong fundamentals and technicals supporting the momentum. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Core Laboratories Inc's Score

Industry at a Glance

Industry Ranking
59 / 160
Overall Ranking
166 / 4614
Industry
Professional & Commercial Services

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 3 analysts
Hold
Current Rating
15.333
Target Price
-0.11%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Core Laboratories Inc Highlights

StrengthsRisks
Core Laboratories Inc. is a provider of proprietary and patented reservoir description and production enhancement services and products for the oil and gas industry. The Company helps to evaluate and improve reservoir performance and increase oil and gas recovery from new and existing fields. It makes measurements of reservoir rocks, reservoir fluids (crude oil, natural gas and water) and their derived products. In addition, the Company assists clients in evaluating subsurface targets associated with carbon capture and sequestration projects or initiatives. The Company has two segments. Reservoir Description segment provides laboratory-based analytical and field services to characterize the properties of crude oil and crude oil-derived products for the oil and gas industry. In addition, it provides reservoir description capabilities. Production Enhancement segment provides integrated diagnostic services. The Company has approximately 70 offices in more than 50 countries.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 523.85M.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 5.97%.
Fairly Valued
The company’s latest PE is 22.28, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 52.28M shares, decreasing 9.26% quarter-over-quarter.
Held by John Rogers
Star Investor John Rogers holds 12.98M shares of this stock.

Financial Health

Currency: USD Updated: 2025-11-07

The company's current financial score is 7.57, which is higher than the Professional & Commercial Services industry's average of 7.31. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 134.52M, representing a year-over-year increase of 0.09%, while its net profit experienced a year-over-year increase of 21.23%.

Score

Industry at a Glance

Previous score
7.57
Change
0

Financials

6.95

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data

Quality of Earnings

6.84

Operational Efficiency

7.03

Growth Potential

7.88

Shareholder Returns

9.15

Core Laboratories Inc's Company Valuation

Currency: USD Updated: 2025-11-07

The company’s current valuation score is 5.35, which is lower than the Professional & Commercial Services industry's average of 7.13. Its current P/E ratio is 22.28, which is 183.81% below the recent high of 63.24 and 32.70% above the recent low of 15.00.

Score

Industry at a Glance

Previous score
5.35
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 59/160
No Data

Earnings Forecast

Currency: USD Updated: 2025-11-07

The company’s current earnings forecast score is 6.00, which is lower than the Professional & Commercial Services industry's average of 7.66. The average price target for Core Laboratories Inc is 14.00, with a high of 22.00 and a low of 10.00.

Score

Industry at a Glance

Previous score
6.00
Change
0

Support & Resistance

No Data

Analyst Rating

Based on 3 analysts
Hold
Current Rating
15.333
Target Price
-0.11%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

74
Total
5
Median
8
Average
Company name
Ratings
Analysts
Core Laboratories Inc
CLB
3
Block Inc
XYZ
45
PayPal Holdings Inc
PYPL
45
Visa Inc
V
41
Fiserv Inc
FI
36
Global Payments Inc
GPN
32
1
2
3
...
15

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-07

The company’s current price momentum score is 9.01, which is higher than the Professional & Commercial Services industry's average of 7.01. Sideways: Currently, the stock price is trading between the resistance level at 18.44 and the support level at 11.28, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
9.01
Change
0

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(2)
Neutral(3)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
-0.030
Neutral
RSI(14)
60.277
Neutral
STOCH(KDJ)(9,3,3)
18.605
Sell
ATR(14)
0.903
High Vlolatility
CCI(14)
-18.179
Neutral
Williams %R
37.611
Buy
TRIX(12,20)
1.353
Sell
StochRSI(14)
4.597
Oversold
Moving Average
Sell(2)
Neutral(0)
Buy(4)
Indicators
Value
Direction
MA5
15.664
Sell
MA10
15.966
Sell
MA20
14.331
Buy
MA50
13.063
Buy
MA100
12.260
Buy
MA200
13.029
Buy

Institutional Confidence

Currency: USD Updated: 2025-11-07

The company’s current institutional recognition score is 10.00, which is higher than the Professional & Commercial Services industry's average of 6.93. The latest institutional shareholding proportion is 112.27%, representing a quarter-over-quarter decrease of 2.96%. The largest institutional shareholder is John Rogers, holding a total of 12.98M shares, representing 27.87% of shares outstanding, with 35.83% increase in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
Ariel Investments, LLC
Star Investors
12.98M
+3.01%
BlackRock Institutional Trust Company, N.A.
6.47M
-2.89%
Disciplined Growth Investors, Inc.
5.44M
-0.93%
EARNEST Partners, LLC
3.60M
-0.75%
The Vanguard Group, Inc.
Star Investors
4.47M
-17.34%
State Street Investment Management (US)
2.16M
+11.82%
Dimensional Fund Advisors, L.P.
1.17M
+20.25%
Geode Capital Management, L.L.C.
1.11M
+3.04%
T. Rowe Price Investment Management, Inc.
875.04K
-20.35%
Fisher Investments
Star Investors
867.73K
-14.22%
1
2

Risk Assessment

Currency: USD Updated: 2025-11-07

The company’s current risk assessment score is 4.63, which is lower than the Professional & Commercial Services industry's average of 5.57. The company's beta value is 1.09. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.

Score

Industry at a Glance

Previous score
4.63
Change
0
Beta vs S&P 500 index
1.09
VaR
+5.05%
240-Day Maximum Drawdown
+54.23%
240-Day Volatility
+59.29%

Return

Best Daily Return
60 days
+28.82%
120 days
+28.82%
5 years
+28.82%
Worst Daily Return
60 days
-9.11%
120 days
-12.20%
5 years
-12.20%
Sharpe Ratio
60 days
+2.30
120 days
+1.11
5 years
-0.02

Risk Assessment

Maximum Drawdown
240 days
+54.23%
3 years
+64.49%
5 years
+79.84%
Return-to-Drawdown Ratio
240 days
-0.50
3 years
-0.11
5 years
-0.13
Skewness
240 days
+1.86
3 years
+1.35
5 years
+0.82

Volatility

Realised Volatility
240 days
+59.29%
5 years
+55.55%
Standardised True Range
240 days
+4.53%
5 years
+7.04%
Downside Risk-Adjusted Return
120 days
+218.18%
240 days
+218.18%
Maximum Daily Upside Volatility
60 days
+69.44%
Maximum Daily Downside Volatility
60 days
+44.57%

Liquidity

Average Turnover Rate
60 days
+1.08%
120 days
+1.07%
5 years
--
Turnover Deviation
20 days
+11.90%
60 days
+22.27%
120 days
+21.56%

Peer Comparison

Professional & Commercial Services
Core Laboratories Inc
Core Laboratories Inc
CLB
7.16 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
S&P Global Inc
S&P Global Inc
SPGI
8.57 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Huron Consulting Group Inc
Huron Consulting Group Inc
HURN
8.46 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Deluxe Corp
Deluxe Corp
DLX
8.42 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Genpact Ltd
Genpact Ltd
G
8.36 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Brinks Co
Brinks Co
BCO
8.34 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI